You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
Journal of Clinical Medicine
Download PDF
  • Article
  • Open Access

18 April 2023

Evolution of Quality of Life and Treatment Adherence after One Year of Intermittent Bladder Catheterisation in Functional Urology Unit Patients

,
,
,
,
,
,
,
,
and
1
Nursing and Nutrition Department, Universidad Europea de Madrid, 28670 Madrid, Spain
2
Department of Nursing, Physiotherapy and Occupational Therapy, Ciudad Real Faculty of Nursing, University of Castilla-La Mancha, 13071 Ciudad Real, Spain
3
Department of Nursing, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain
4
Department of Nursing, Hospital Universitari Clinic Barcelona, 08036 Barcelona, Spain
J. Clin. Med.2023, 12(8), 2928;https://doi.org/10.3390/jcm12082928
This article belongs to the Section Nephrology & Urology
Version Notes
Order Reprints

Abstract

Objective: To determine patient difficulties and concerns when performing IBC (Intermittent Bladder Catheterisation), as well as the evolution of adherence, quality of life, and emotional state of patients one year after starting IBC. Method: A prospective, observational, multicentre study conducted in 20 Spanish hospitals with a one-year follow-up. Data sources were patient records and the King’s Health Questionnaire on quality of life, the Mini-Mental State Examination (MMSE), and the Hospital Anxiety and Depression Scale (HADS). Perceived adherence was measured using the ICAS (Intermittent Catheterization Adherence Scale) and perceived difficulties with IBC were assessed using the ICDQ (Intermittent Catheterization Difficulty Questionnaire). For data analysis, descriptive and bivariate statistics were performed for paired data at three points in time (T1: one month, T2: three months, T3: one year). Results: A total of 134 subjects initially participated in the study (T0), becoming 104 subjects at T1, 91 at T2, and 88 at T3, with a mean age of 39 years (standard deviation = 22.16 years). Actual IBC adherence ranged from 84.8% at T1 to 84.1% at T3. After one year of follow-up, a statistically significant improvement in quality of life (p ≤ 0.05) was observed in all dimensions with the exception of personal relationships. However, there were no changes in the levels of anxiety (p = 0.190) or depression (p = 0.682) at T3 compared to T0. Conclusions: Patients requiring IBC exhibit good treatment adherence, with a significant proportion of them performing self-catheterisation. After one year of IBC, a significant improvement in quality of life was noted, albeit with a significant impact on their daily lives and their personal and social relationships. Patient support programmes could be implemented to improve their ability to cope with difficulties and thus enhance both their quality of life and the maintenance of their adherence.

1. Introduction

Intermittent bladder catheterisation (IBC) involves periodically emptying the urinary bladder by inserting a catheter through the urethra and removing it when voiding is complete. This procedure may be indicated in both the short and long term for conditions such as urinary retention or neurogenic bladder dysfunction (e.g., spinal cord injury, myelomeningocele, atonic bladder) [,,]. IBC is therefore considered the treatment of choice for voiding dysfunction with chronic urinary retention and to protect the upper urinary tract [,]. It also provides greater independence for the individual and improves aspects such as social, work, and school integration, couple relationships, self-esteem, and overall quality of life [,,]. This procedure therefore not only promotes patient autonomy, but also helps to preserve renal function and maintain the patient’s urological health.
However, a number of authors have identified different factors that may play a role in the lack of IBC adherence. These include lack of privacy and suitable spaces in public places, as well as the need for assistance to perform the procedure, lack of time, and the need for catheterisation planning [,,,]. Additionally, another phenomenon observed is that certain patients do not follow the recommendations for IBC, especially with regard to the number of catheterisations prescribed and long-term compliance [].
Furthermore, although the relationship between IBC and the improvement of patient quality of life and emotional state has been previously explored, few studies have been published on the topic [,,], most of them using qualitative designs [,,,,] and small sample sizes. In 2021, our research team published the results of a pilot study where these aspects were evaluated after a one-month follow-up of IBC, yielding positive results; however, we ignored whether these results can be maintained in the long term [].
For these reasons, the aim of this study was to identify the difficulties and concerns surrounding the implementation of IBC, as well as the evolution of patient adherence, quality of life, and emotional state one year after initiating IBC.

2. Method

2.1. Design

This is a prospective, observational, multicentre study that was carried out in 20 hospitals across 11 Spanish cities from 15 October 2020 to 15 December 2021. The study started with a cohort of patients whose results were published in 2021 [].

2.2. Selection of Study Subjects

The reference population consisted of patients who performed IBC and were seen at the functional urology units participating in the study. The inclusion criteria were being 18 years of age or older and that this was the first time that catheterisation was prescribed to them. The exclusion criteria included language barriers and cognitive and/or sensory impairments preventing patients from performing IBC and understanding the purpose of the study.
As a result, the study population consisted of patients from the reference population who met the inclusion criteria and voluntarily agreed to participate. The criteria for patient withdrawal from the study were the following: a change of hospital, a decision to withdraw from the study, end of treatment, or exitus during the study.

2.3. Sample Size Calculation

The Granmo tool was used to estimate the required sample size (https://www.imim.es/ofertadeserveis/software-public/granmo/, accessed on 1 February 2023). We took the following into consideration: a 95% confidence level; an unknown reference population susceptible to requiring IBC because of their particular health conditions; a prevalence of 50%, which is the most demanding for estimating a sample size; a 10% precision error; and a 10% replacement rate. These criteria resulted in a sample size of 107 study subjects.

2.4. Sources of Information and Study Variables

Patient records and a data collection notebook developed specifically for this study were used as sources of information. This notebook included a questionnaire of our own design that assessed the frequency and level of difficulties performing IBC, as well as validated tools to assess the following: cognitive state, using the Mini-Mental State Examination [] (where lower scores indicate poorer cognitive states); anxiety and depression, using the Hospital Anxiety and Depression Scale or HADS [] (where higher scores indicate higher levels of anxiety and depression); quality of life linked to urinary problems, using King’s Health Questionnaire [] (where higher scores indicate a poorer quality of life); perceived adherence, using the ICAS (Intermittent Catheterization Adherence Scale) []; and perceived difficulties in performing IBC, using the modified ICDQ (Intermittent Catheterization Difficulty Questionnaire) [].
The main outcome variable of the study was treatment adherence, understood as the maintenance of the number of IBCs prescribed by the practitioner. Other outcome variables were perceived IBC adherence as measured using the ICAS; changes in quality of life according to King’s Health Questionnaire; and changes in emotional state based on the HADS. The independent variables were sociodemographic, anthropometric, and clinical in nature, as well as determinants of previous cognitive state, previous anxiety, previous depression, and previous quality of life.

2.5. Patient Recruitment and Follow-Up

Patients who had just received a prescription for IBC were contacted by the nurse researchers from the participating facilities. They invited all patients to participate in the study and informed them of all the study details following a non-probabilistic consecutive sampling method.
Once they agreed to participate and signed the informed consent form, participants were asked for additional data that are not usually included in clinical records.
The participating nurses carried out their care work by briefing and training patients to comply with IBC treatment following the standard guidelines of each unit/department. At that time, they filled in the data collection notebook together with the HADS, the Mini-Mental Status Examination, and King’s Health Questionnaire (T0).
The nurses then phoned the patients for a one-month follow-up (T1), for a 3-month follow-up (T2), and for a 12-month follow-up (T3) to ascertain whether they continued performing IBC and their reasons for discontinuation, if applicable. In each of these telephone calls, the following were completed: the follow-up notebook, the quality-of-life questionnaire (King’s Health Questionnaire), the anxiety and depression questionnaire (HADS), the perceived adherence scale (ICAS), and the questionnaire of perceived difficulties in performing IBC (modified ICDQ).

2.6. Statistical Analysis

Firstly, descriptive statistics were performed for all the study variables: absolute and relative frequencies for qualitative variables; and means and standard deviations for quantitative variables with a normal distribution, or alternatively, medians and interquartile ranges.
Changes in perceived difficulties performing IBC, the evolution of adherence, and ICAS adherence scores between the first month and one year after the initial IBC were then assessed using Wilcoxson’s non-parametric test for paired data, McNemar’s test, or Student–Fisher’s t-test for paired data, depending on whether the variable in question was ordinal, dichotomous, or quantitative in nature. Lastly, changes in quality of life and changes in anxiety/depression levels between baseline (T0) and 12 months (T3) were assessed using Student–Fisher’s t-test for paired data. The SPSS 28.0 statistical package was used for all analyses.

2.7. Ethical and Legal Considerations

This observational study was based on anonymised data and designed in accordance with the Declaration of Helsinki as laid out by the World Medical Association (WMA). The study was approved by the Clinical Research Ethics Committees at the recruitment hospitals.
Patients were invited to participate in the study and received a patient information sheet. The particulars of the study were verbally explained to them, and they were required to sign the informed consent form. If patients wished to take part in the study, their personal data were attributed numerical codes for confidentiality.
Additionally, the study complied with the Spanish Organic Law 3/2018 of 5 December, on Personal Data Protection and Guarantee of Digital Rights, ensuring the anonymity of the participants and the database, with no personally identifiable data.

3. Results

Characteristics of the Subjects Included in the Study

A total of 134 subjects initially participated in the study (T0), becoming 104 subjects at T1, 91 subjects at T2, and 88 subjects at T3. The most relevant sociodemographic characteristics of the patients at the beginning of the study included a mean age of 39.0 years (SD = 22.16 years), with 55.2% (n = 74) of the sample being male, 45.5% (n = 61) having a primary education, and 46.3% (n = 62) being retired; 88.1% (118) were living at home with family and/or caregiver support. Table 1 provides all of the patient sociodemographic information.
Table 1. Sociodemographic characteristics of the participating patients.
In terms of clinical characteristics, it was observed that 32.8% (n = 44) of participants presented neurological damage for which IBC was prescribed, followed by impaired contractile function, at 30.6% (n = 41). Cardiovascular conditions ranked first, at 24.6% (n = 33) of pre-existing conditions, followed by musculoskeletal conditions, at 19.4% (n = 26). Comorbidities included obesity, at 14.2% (19), followed by previous depression and anxiety, both at 9.7% (n = 13). Catheterisation was prescribed by a urologist in 91.0% (n = 122) of patient cases and by a nurse in 11.2% (n = 15) of them. The clinical characteristics can be found in Table 2.
Table 2. Clinical characteristics of the study patients.
Regarding their ability to self-care, hand function was assessed, revealing that only 5.2% (n = 7) had limited motor skills in both hands, 2.2% (n = 3) in the dominant hand only, and 11.2% (n = 15) had limited sensation in both hands. Mobility was also assessed and only 60.4% (n = 81) were found to have normal mobility. Additionally, 20.9% (n = 28) of patients reported difficulty in locating their urinary meatus. Regarding their ability to repeat and understand the information provided on IBC, most patients (97.0%; n = 130 and 92.5%; n = 124, respectively) were found to be able to do so. In this first assessment, 88.1% (n = 118) of patients believed that they would need help to perform IBCs (Table 3).
Table 3. Characteristics relating to the ability to self-care.
Patients were then surveyed about their concerns regarding the use of IBC. A percentage assessment was made based on their degree of concern on a Likert scale ranging from ‘No concern’ to ‘Very concerned’. Focusing on the ‘Very concerned’ category, the most concerning aspect for patients was the risk of infection (5.2%; n = 7), with this item also having the highest mean and median scores when considering all the response options together. As for the category ‘No concern’, the aspect with the highest percentage of responses was the feeling of losing masculinity or femininity, with 71.6% (n = 96), which also coincides with the lowest mean and median scores. Table 4 provides this information in further detail.
Table 4. Patients’ degree of concern over different problems that could be attributed to the catheterisation at the first visit.
Regarding cognitive state, 91.0% (n = 122) obtained normal values, and there was only 1 subject with scores consistent with dementia. In terms of quality of life, the most affected dimensions were incontinence impact and personal relationships, and 11.9% (n = 16) cases of anxiety and 8.2% (n = 11) cases of depression were observed. These, and the rest of the related data can be consulted in Table 5.
Table 5. Cognitive characteristics, quality of life, and psychological state of the study patients at the first visit (T0). HADS—Hospital Anxiety and Depression Scale.
After one month of follow-up, the researchers contacted the patients to assess their condition, to ascertain whether they continued performing IBC, and to discuss their experience and how this had impacted their quality of life and their levels of anxiety and depression (Table 6).
Table 6. Characteristics of the catheter used and its use. Second visit.
Firstly, they were asked about the type of catheter they had used, with 72.4% (n = 79) using a ready-to-use hydrophilic catheter. Interestingly, 79.8% (n = 95) of patients performed their IBC independently, despite the fact that, at the beginning of the study, most of them believed that they would need assistance.
The difficulties patients had experienced in performing bladder catheterisation, both in terms of level and frequency were also analysed. Although patients were originally asked a 4-point Likert question (ranging from 0 to 3 points), the mean score for each suggested difficulty was calculated to create an overall picture of the most problematic aspects. Specifically, the aspect with the highest mean score was ‘Public bathrooms do not meet hygienic requirements’, followed by ‘I could not find a private place’ both in terms of frequency and level. The evolution of the average difficulty scores both in terms of frequency and level during the follow-up period is presented below. Regarding the changes experienced, there was only a statistically significant improvement between T1 and T3 in ‘locating the urinary meatus’ and ‘catheterisation using the no-touch technique’. In contrast, there was a statistically significant worsening of ‘problems accessing public toilets’ and ‘not finding a private place’. All information about difficulties experienced with IBC can be found in Table 7.
Table 7. Evolution of adherence to and continued use of IBC. ICAS—Interpersonal Communication Assessment Scale.
Actual IBC adherence (maintaining the prescribed number of catheterisations) and adherence—as assessed using the quantitative and categorical versions of the ICAS—did not experience statistically significant changes (p > 0.05) throughout the follow-up period between T1 and T3. As a result, actual adherence values ranged from 84.8% at T1 to 84.1% at T3.
Finally, changes in quality of life and in the anxiety/depression scale during the one-year follow-up were assessed by comparing the baseline situation (recruitment visit, T0) with the last visit (T3; n = 79). As shown in Table 8, there was a statistically significant improvement in quality of life (p ≤ 0.05) (lower King’s Health scores) in all dimensions with the exception of personal relationships. However, there were no changes in levels of anxiety (p = 0.190) or depression (p = 0.682) at visit T3 compared to T0 (Table 9).
Table 8. Difficulty performing bladder catheterisation at the three cut-off points.
Table 9. Evolution of adherence, quality of life, and emotional state during follow-up between T1 and T6.

4. Discussion

The main findings of our study include, firstly, the great variability of clinical and sociodemographic characteristics of IBC users, which is in line with other studies [,]. As such, although most of our sample exhibited a good mental state and were able to follow the instructions for proper IBC, more than half of the patients had some type of mobility issue and a number of them even had difficulty locating the urinary meatus. However, despite this, almost 80% performed self-catheterisations, which is in line with what other authors have reported [,]. In fact, IBC is a procedure that can be performed by individuals of all ages, including the elderly and children from 4–5 years of age under adult supervision. Training and close monitoring by nurses specialising in functional urology is essential to performing IBC properly. These nurses not only train patients in the performance of the technique, but also in their self-care and in the successful integration of the treatment into their daily lives. One of the results of our study is a reduction in the difficulty in locating the urinary meatus and in the ‘no touch’ technique throughout the follow-up period. This is supported by a recent patient support study that showed an increase in IBC adherence as well as a decrease in the number of related emergency consultations and hospitalisations []. Patient support programmes are of great interest, especially at the beginning of treatment, when patients tend to drop out due to difficulties performing the technique or because of fear of IBC []. Such training should have a strong health education component, aiming to dispel concerns about IBC, such as the fear of infection, which is the main concern reported by the patients in our study. Training is therefore considered a key determinant of treatment adherence [].
Furthermore, the participants in this study reported a great variability in the equipment used for IBC, employing up to 7 types of catheters made of different materials and with different technical features. The reason for choosing one type of catheter over another is to promote IBC adherence and avoid related complications, always depending on the preferences and clinical characteristics of each patient. We therefore concur with other authors that the choice of equipment should be tailored to the needs and preferences of the patient and comfort criteria for catheter handling according to the model []. Restricting the type of equipment used could result in treatment abandonment, especially in the early stages, as well as complications such as haematuria or urethrorrhagia. For instance, when a patient is at risk of urethral microtrauma, it is recommended that the patient be trained in the use of hydrophilic catheters [].
Another of the aspects explored in this study were the difficulties and/or barriers reported by the patients, who highlighted that public toilets did not meet the required hygienic conditions for catheterisation and that they could not find a private place to conduct catheterisation in public spaces. The same barriers were identified by Cobussen et al. []. These problems illustrate the need to select equipment for patients that is as sterile and easy to use as possible, facilitating a ‘no touch’ technique, while avoiding disruption of their social life (travel, leisure activities, work), and thereby improving their quality of life.
Despite the variability in both the profile of patients performing IBC and the difficulties observed, there was a high percentage of IBC adherence (84.1% at one-year follow-up). This percentage is higher than those published by other authors such as Hentzen et al. [] (66.9%) and Montavaselli et al. [] (29%) at one-month follow-up, as well as a study by Girotti et al. [] (58%).
We therefore believe that this success is a consequence of the strong involvement of specialised nurses in patient training. This conclusion is supported by other studies such as the one published by Hasan et al. [] in 2022, where, after implementing a patient support programme, adherence improved (up to 88% at one-month follow-up), and the number of visits to the emergency department also decreased in the first month of follow-up.
Regarding the impact of IBC on quality of life and mood, we observed a significant short-term improvement in quality of life, in agreement with other authors []. However, these authors also acknowledged that it is crucial for patients, especially older people, to receive adequate support from trained nurses in the early stages. Our study shows that, although IBC treatment generally improves the quality of life of individuals, it has a significant impact on their daily lives and their personal and social relationships. This would justify the implementation of support programmes to help patients cope better with their problems and thus improve both their quality of life and the maintenance of adherence. However, there appears to be clear evidence that intermittent self-catheterisation is the technique that provides the most positive outcomes in terms of quality of life, as reported in the 2022 systematic review by Gharbi et al. [] involving 25 studies and 3002 patients with neurogenic bladder dysfunction.
There was also an improvement in the initially published cut-off levels of anxiety/depression []. However, we observed no differences at one-year follow-up. Training may have a positive effect in the early stages, but it may stabilise or even deteriorate over time.
For this reason, it would be interesting to work on all these aspects in patient support programmes as suggested by other authors [], since higher levels of anxiety/depression, a greater impact on the patient’s normal daily life, and disruption of personal relationships have been linked to poorer IBC adherence [].
One of the main limitations of our study was the loss of 20 subjects as a consequence of the COVID-19 pandemic. However, despite these limitations, our study recruited more subjects than most published studies [,,,,,], most of them being qualitative and short-term in nature [,,,,]. Finally, we believe that the results obtained may vary depending on the population selected. For instance, if there are many patients with poor motor skills who require assisted catheterisation, they may not perform as well as if catheterisation was performed on their own, as noted in a review by Gharbi et al. [].
One of the main strengths of this study is that it addresses a topic with scarce international studies and is one of the few to cover a one-year follow-up period. Moreover, this is the first study to examine this problem in Spain taking a multicentre approach, in which patients from 20 Spanish hospitals are represented. Subject selection was rigorous and systematic, which is why we believe that any confounding bias may be minimal. In addition, validated and widely used tools were used to measure the phenomena under study.

5. Conclusions

In light of the above, we believe that patients requiring IBC exhibit good treatment adherence, with a significant proportion of them performing self-catheterisation. After one year of IBC, a significant improvement in quality of life was noted, albeit with a significant impact on their daily lives and their personal and social relationships Nevertheless, it appears necessary to offer patients support programmes that also address emotional issues and coping skills to improve their quality of life and the maintenance of their adherence.

Author Contributions

Methodology, E.A.Z. and R.S.-A.; Validation, M.A.G.M. and M.L.V.E.; Formal analysis, A.H.M. and M.R.D.; Investigation, C.L.G., M.B.P., A.T.B., G.F.F., B.B.S., M.P.L.L., F.B.B., G.A.M., M.M.M., V.L.M., S.T.R., R.A.R.C. and M.M.V.; Resources, M.B.P., G.F.L. and I.J.M.; Data curation, C.L.G.; Writing—original draft, F.E.G. and M.C.G.A.; Writing—review & editing, M.V.M.B.; Visualization, M.A.O.C.; Project administration, B.F.-L.B. and J.R.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee in Clinical Research (CEIC) of the Hospital Clínico de San Carlos in Madrid (Protocol Number C.I. 19/156-O).

Data Availability Statement

The data that support the findings of this study are available from the author [BFLB], upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Moore, K.N.; Burt, J.; Voaklander, D.C. Intermittent catheterization in the rehabilitation setting: A comparison of clean and sterile technique. Clin. Rehabil. 2006, 20, 461–468. [Google Scholar] [CrossRef] [PubMed]
  2. Assis, G.M.; Faro, A.C.M. Autocateterismo vesical intermitente na lesão medular. Rev. Esc. Enferm. USP 2011, 45, 289–293. [Google Scholar] [CrossRef] [PubMed]
  3. Gould, C.V.; Umscheid, C.A.; Agarwal, R.K.; Kuntz, G.; Pegues, D.A. Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009. Infect. Control Hosp. Epidemiol. 2010, 31, 319–326. [Google Scholar] [CrossRef] [PubMed]
  4. Stöhrer, M.; Blok, B.; Castro-Diaz, D.; Chartier-Kastler, E.; Del Popolo, G.; Kramer, G.; Pannek, J.; Radziszewski, P.; Wyndaele, J.-J. EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction. Eur. Urol. 2009, 56, 81–88. [Google Scholar] [CrossRef]
  5. Adams, J.; Watts, R.; Yearwood, M.; Watts, A.; Hartshorn, C.; Simpson, S.; Consultant, K.A.C.N.; Denison, S.; Hardcastle, B. Strategies to promote intermittent self-catheterisation in adults with neurogenic bladders: A comprehensive systematic review. JBI Libr. Syst. Rev. 2011, 9, 1392–1446. [Google Scholar] [CrossRef] [PubMed]
  6. Torres Alaminos, M.A. Medidas preventivas para evitar complicaciones de salud derivadas del uso de sondajes vesicales en pacientes lesionados medulares. Enfermería Glob. 2013, 12, 2. [Google Scholar] [CrossRef]
  7. Aparicio Hormigo, J.; Jiménez Mayorga, I.E.; Díaz Rodríguez, F.; Cuenca García, J.A. Enfuro Revista de la Asociación Española de Enfermería En Urología; Asociación Española de Enfermería en Urología: Madrid, Spain, 2003. [Google Scholar]
  8. Wyndaele, J. Complications of intermittent catheterization: Their prevention and treatment. Spinal Cord 2002, 40, 536–541. [Google Scholar] [CrossRef]
  9. Vaidyanathan, S.; Soni, B.M.; Dundas, S.; Krishnan, K.R. Urethral cytology in spinal cord injury patients performing intermittent catheterisation. Spinal Cord 1994, 32, 493–500. [Google Scholar] [CrossRef]
  10. Perrouin-Verbe, B.; Labat, J.J.; Richard, I.; Mauduyt de la Greve, I.; Buzelin, J.M.; Mathe, J.F. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Spinal Cord 1995, 33, 619–624. [Google Scholar] [CrossRef]
  11. Wyndaele, J.J. Intermittent catheterization: Which is the optimal technique? Spinal Cord 2002, 40, 432–437. [Google Scholar] [CrossRef]
  12. Bolinger, R.; Engberg, S. Barriers, complications, adherence, and self-reported quality of life for people using clean intermittent catheterization. J. Wound Ostomy Cont. Nurs. 2013, 40, 83–89. [Google Scholar] [CrossRef] [PubMed]
  13. Cobussen-Boekhorst, H.; Beekman, J.; van Wijlick, E.; Schaafstra, J.; van Kuppevelt, D.; Heesakkers, J. Which factors make clean intermittent (self) catheterisation successful? J. Clin. Nurs. 2016, 25, 1308–1318. [Google Scholar] [CrossRef] [PubMed]
  14. Fernandez-Lasquetty Blanc, B.; Rodríguez-Almagro, J.; Lorenzo-García, C.; Alcaraz-Zomeño, E.; Fernandez-Llorente, G.; Baixauli-Puig, M.; Martín-Bermejo, M.V.; Estudillo-González, F.; Ortega-Checa, M.A.; Lluesma-Martinez, V.; et al. Quality of life and autonomy in patients with intermittent bladder catheterization trained by specialized nurses. J. Clin. Med. 2021, 10, 3909. [Google Scholar] [CrossRef]
  15. Cobussen-Boekhorst, H.; Hermeling, E.; Heesakkers, J.; van Gaal, B. Patients’ experience with intermittent catheterisation in everyday life. J. Clin. Nurs. 2016, 25, 1253–1261. [Google Scholar] [CrossRef] [PubMed]
  16. Goldstine, J.; Leece, R.; Samas, S.; Zonderland, R. In Their Own Words: Adults’ Lived Experiences with Intermittent Catheterization. J. Wound Ostomy Cont. Nurs. 2019, 46, 513–518. [Google Scholar] [CrossRef] [PubMed]
  17. Logan, K.; Shaw, C.; Webber, I.; Samuel, S.; Broome, L. Patients’ experiences of learning clean intermittent self-catheterization: A qualitative study. J. Adv. Nurs. 2008, 62, 32–40. [Google Scholar] [CrossRef]
  18. Nørager, R.; Bøgebjerg, C.; Plate, I.; Lemaitre, S. Supporting better adherence among patients engaged in intermittent self-catherisation. Br. J. Nurs. 2019, 28, 90–95. [Google Scholar] [CrossRef]
  19. Lobo, A.; Saz, P.; Marcos, G.; Día, J.L.; De La Cámara, C.; Ventura, T.; Asín, F.M.; Pascual, L.F.; Montañés, J.A.; Aznar, S. Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med. Clin. (Barc.) 1999, 112, 767–774. [Google Scholar]
  20. Herrero, M.J.; Blanch, J.; Peri, J.M.; De Pablo, J.; Pintor, L.; Bulbena, A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen. Hosp. Psychiatry 2003, 25, 277–283. [Google Scholar] [CrossRef]
  21. Romero-Cullerés, G.; Sánchez-Raya, J.; Conejero-Sugrañes, J.; González-Viejo, M.Á. Validation of the Spanish version of the King’s Health questionnaire for evaluating quality of life related to urinary incontinence in patients with spinal cord injury. Med. Clin. (Barc.) 2011, 137, 491–494. [Google Scholar] [CrossRef]
  22. Guinet-Lacoste, A.; Charlanes, A.; Chesnel, C.; Blouet, E.; Tan, E.; Le Breton, F.; Amarenco, G. Intermittent Catheterization Adherence Scale (ICAS): A new tool for the evaluation of patient adherence with clean intermittent self-catheterization. Neurourol. Urodyn. 2018, 37, 2753–2757. [Google Scholar] [CrossRef] [PubMed]
  23. Guinet-Lacoste, A.; Jousse, M.; Tan, E.; Caillebot, M.; le Breton, F.; Amarenco, G. Intermittent catheterization difficulty questionnaire (ICDQ): A new tool for the evaluation of patient difficulties with clean intermittent self-catheterization. Neurourol. Urodyn. 2016, 35, 85–89. [Google Scholar] [CrossRef] [PubMed]
  24. Chiappe, S.G.; Lasserre, A.; Chartier Kastler, E.; Falchi, A.; Blaizeau, F.; Blanchon, T.; Hanslik, T.; Denys, P. Use of clean intermittent self-catheterization in France: A survey of patient and GP perspectives. Neurourol. Urodyn. 2016, 35, 528–534. [Google Scholar] [CrossRef] [PubMed]
  25. Faleiros, F.; de Oliveira Käppler, C.; Rosa, T.; Gimenes, F.R.E. Intermittent catheterization and urinary tract infection: A comparative study between Germany and Brazil. J. Wound Ostomy Cont. Nurs. 2018, 45, 521–526. [Google Scholar] [CrossRef] [PubMed]
  26. Arlandis Guzmán, S.; Ruiz Cerdá, J.L.; Martínez Agulló, E. Las pruebas funcionales urodinámicas en el diagnóstico de la vejiga neurógena. Rehabilitacion 2005, 39, 343–357. [Google Scholar] [CrossRef]
  27. Al Hasan, S.; Neal-Herman, L.; Norman, H.S.; Zhao, J.Z.; Carlson, A. Patient Support Program and Healthcare Resource Utilization in Patients Using Clean Intermittent Catheterization for Bladder Management. J. Wound Ostomy Cont. Nurs. 2022, 49, 470–480. [Google Scholar] [CrossRef]
  28. Hentzen, C.; Turmel, N.; Chesnel, C.; Miget, G.; Le Breton, F.; Charlanes, A.; Tan, E.; Amarenco, G. What criteria affect a patient’s choice of catheter for self-catheterization? Neurourol. Urodyn. 2020, 39, 412–419. [Google Scholar] [CrossRef]
  29. Liao, X.; Liu, Y.; Liang, S.; Li, K. Effects of hydrophilic coated catheters on urethral trauma, microtrauma and adverse events with intermittent catheterization in patients with bladder dysfunction: A systematic review and meta-analysis. Int. Urol. Nephrol. 2022, 54, 1461–1470. [Google Scholar] [CrossRef]
  30. Hentzen, C.; Haddad, R.; Ismael, S.S.; Peyronnet, B.; Gamé, X.; Denys, P.; Robain, G.; Amarenco, G.; Manceau, P. Predictive factors of adherence to urinary self-catheterization in older adults. Neurourol. Urodyn. 2019, 38, 770–778. [Google Scholar] [CrossRef]
  31. Motavasseli, D.; Chesnel, C.; Charlanes, A.; Menoux, D.; Charoenwong, F.; Le Breton, F.; Amarenco, G. Adherence to anticholinergic therapy and clean intermittent self-catheterization in patients with multiple sclerosis. Int. Neurourol. J. 2018, 22, 133–141. [Google Scholar] [CrossRef]
  32. Girotti, M.E.; MacCornick, S.; Perissé, H.; Batezini, N.S.; Almeida, F.G. Determining the variables associated to clean intermittent selfcatheterization adherence rate: One-year follow-up study. Int. Braz. J. Urol. 2011, 37, 766–772. [Google Scholar] [CrossRef] [PubMed]
  33. Gharbi, M.; Gazdovich, S.; Bazinet, A.; Cornu, J.N. Quality of life in neurogenic patients based on different bladder management methods: A review. Prog. Urol. 2022, 32, 784–808. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Download PDF
Role of Doxycycline as an Osteoarthritis Disease-Modifying Drug
Previous
A Supplement with Ribes Nigrum, Boswellia Serrata, Bromelain and Vitamin D to Stop Local Inflammation in Chronic Sinusitis: A Case-Control Study
Next